Related Experiment Video
Updated: Nov 25, 2025

Fluorescence Assays for the Study of Mycobacterium tuberculosis Interaction with the Immune Receptor SLAMF1
Published on: February 28, 2025
Two-Way Regulation of MmpL3 Expression Identifies and Validates Inhibitors of MmpL3 Function in Mycobacterium
Shipra Grover1, Curtis A Engelhart1, Esther Pérez-Herrán2
1Department of Microbiology and Immunology, Weill Cornell Medicine, New York, New York 10065, United States.
Abstract:
MmpL3, an essential mycolate transporter in the inner membrane of Mycobacterium tuberculosis (Mtb), has been identified as a target of multiple, chemically diverse antitubercular drugs. However, several of these molecules seem to have secondary targets and inhibit bacterial growth by more than one mechanism. Here, we describe a cell-based assay that utilizes two-way regulation of MmpL3 expression to readily identify MmpL3-specific inhibitors. We successfully used this assay to identify a novel guanidine-based MmpL3 inhibitor from a library of 220 compounds that inhibit growth of Mtb by largely unknown mechanisms. We furthermore identified inhibitors of cytochrome bc1-aa3 oxidase as one class of off-target hits in whole-cell screens for MmpL3 inhibitors and report a novel sulfanylacetamide as a potential QcrB inhibitor.
Related Concept Videos
Master Transcription Regulators
Abnormal Proliferation
Riboswitches
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The JAK-STAT Signaling Pathway

